Guide

With GST, however, simplicity is suddenly able to yield rich dividends for drug manufacturers. And they’re getting rid of dead weight. Upendra Dinani, chairman and managing director of Nasik-based D. Vijay Pharma, a distributor, and C&F for multiple pharma companies, knew times were going to be tough post-GST. In April 2017, Emcure Pharmaceuticals went from … Read moreFew Steps from Creation to the Consumption

“I think Absorb has dampened the enthusiasm for companies,” Sripal Bangalore, a cardiologist at New York University who has done clinical trials for Abbott, said. “It’s still a lot of investment to kind of fine-tune this technology. But I’m hoping that other companies with thinner scaffolds will have favorable results.” Abbott, too, is working on … Read moreIt was reported that thrombosis occurred in the Absorb

Seher could not have been happier when she found out that she was pregnant in February 2017. As is often the case with overwhelming news, her delight soon turned to confusion. Is maternity leave enough? Where would she find a nanny she could trust? Breast milk or not? Her mother, mother-in-law, and aunts, however, had … Read moreC-sections and the conundrum of giving birth in India

What, then, do we make of the lack of awareness in India of the rotavirus vaccine’s risk of intussusception? Or of nearly 1% of PCV users reporting adverse events like bronchiolitis (an infection of the lungs), gastroenteritis (inflammation of the stomach and small intestine) and pneumonia? Underpinning all this is NTAGI’s non-disclosure clause, where members … Read moreThe government sees serious adverse events

Back in the 1980s, MNCs dominated the Indian pharmaceutical market. They controlled an 80% stake, while domestic companies accounted for the rest. This has reversed starting in the early 2000s, with Indian companies accounting for 79% of the Rs 1,21,833 crore ($16.80 billion)-market, as of FY18. The demoralizing decrease at every stage The market grew … Read moreA Speck in the Multi-Billion Dollar Universe

The president of the Indian Society Of Oncology, Dr. Dinesh Pendharkar, agreed with Menghaney. In cancer treatment, every oncologist needs to follow clinical practice guidelines, said Pendharkar. The most widely followed guidelines globally and in India are written by the national comprehensive cancer network (NCCN) – a US-based not-for-profit alliance of 28 leading cancer centers. … Read moreThe value of a cancer patient’s life

P* is 34. She lives in Borivali, a suburb of Mumbai, the city where she was born and raised. She works at an office in one of the city’s commercial hubs and spends hours on the infamous local trains every day. Much like most people in the city. What was to be followed? But P’s … Read moreGovt’s ‘honest mistaken belief’: 100 million rare disease

This prevalence was not the case a few decades back. “In 2019, everyone knows someone who is dealing with PCOS-related symptoms,” Dr. Pepalla says. “Ten years back, I used to get a maximum of one or two cases every month. Now, we see five to ten cases every two days.” This works out to hundreds … Read moreOf widening definitions and over-prescription

This is a high stakes case that Women and Child Development Minister Maneka Gandhi is close to. As an animal rights activist, she has advocated for the regulation of oxytocin for two decades now. She has attended every hearing even though she’s not a party to the case, claims the petitioners in the Delhi High … Read moreOf birth, death, and cows

It is reliably learned that Biocon bypassed Wellthy, which is found to be a rather inferior copy of Welldoc, a US FDA-approved digital therapy company. Moreover, Wellthy is into lifestyle management. Geographical Diversity in India Whereas the digital tool that Biocon plans to launch will take into consideration geographic diversity in India and focus on … Read moreDiabetes a lifelong disorder, and overcoming the same